Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 5, 2010, Pages 732-736

  Nesher, Nahum ^a   Singh, Steve K ^a   Fawzy, Hosam F ^b   Sever, Jeri Y ^a   Goldman, Bernard E ^a   Cohen, Gideon N ^a   Laflamme, Claude ^a   Fremes, Stephen E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Bleeding; Clopidogrel; Coronary artery bypass surgery; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; CLOPIDOGREL; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; TRANEXAMIC ACID;

AGED; ARTICLE; BLOOD TRANSFUSION; BRAIN ISCHEMIA; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG WITHDRAWAL; EMERGENCY SURGERY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMERGENCY TREATMENT; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TICLOPIDINE;

EID: 77954646024     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.214569     Document Type: Article

References (15)

1. Boneu B, Destelle G. Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 1996;76: 939-943.
2. Jarvis B, Simpson K. clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs 2000;60:347-377.
3. Fox KA, Anderson FA Jr, Dabbous OH, Steg PG, Lopez-Sendon J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007;93:177-182.
4. Alberts MJ, Easton JD. clopidogrel plus aspirin for stroke prevention. Stroke 2002;33:2546-2547.
5. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001;29:2271-2275.
6. Saw J, Topol EJ, Steinhubl SR, Brennan D, Berger PB, Moliterno DJ, CREDO Investigators. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. Am J Cardiol 2004;94:623-625.
7. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494- 502.
8. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001;103:363-368.
9. Lindvall G, Sartipy U, Van der Linden J. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Circulation 2005;112(9 Suppl):I276-I280.
10. Genoni M, Tavakoli R, Hofer C, Bertel O, Turina M. clopidogrel before urgent coronary artery bypass graft. J Thorac Cardiovasc Surg 2003; 126:288-289.
11. w11x Chen L, Bracey AW, Radovancevic R, Cooper-JR Jr, Collard CD, Vaughn WK, Nussmeier NA. clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004; 128:425-431.
12. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1995;334:1685-1690.
13. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA. ACCyAHA 2004 guideline update for coronary artery bypass graft surgery report of the American College of CardiologyyAmerican Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery). Circulation 2004;110:e340-e437.
14. Stamou SC, Reames MK, Skipper E, Stiegel RM, Nussbaum M, Geller R, Robicsek F, Lobdell KW. Aprotinin in cardiac surgery patients: is the risk worth the benefit? Eur J Cardiothorac Surg 2009;36:869-875.
15. Jakobsen CJ, Søndergaard F, Hjortdal VE, Johnsen SP. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study. Eur J Cardiothorac Surg 2009;36:863-868.